Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: A prospective phase II study

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 5, 2002, Pages 460-463

  Stein, Moshe E ^a   Bernstein, Zvi ^a   Tsalic, Mady ^a   Drumea, Karen ^a   Steiner, Marianne ^a   Sklar, Zoya ^a   Haim, Nissim ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Chemoimmunotherapy; Hormonal therapy; Malignant melanoma

Indexed keywords

ALPHA2A INTERFERON; AMINOTRANSFERASE; CARMUSTINE; CISPLATIN; CREATININE; DACARBAZINE; TAMOXIFEN;

ADULT; ALOPECIA; ANEMIA; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER HORMONE THERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL PROTOCOL; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; MELANOMA; METASTASIS; MUCOSA INFLAMMATION; MYOCARDIAL DISEASE; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; OTOTOXICITY; PARESTHESIA; PNEUMONIA; SEPSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CISPLATIN; DACARBAZINE; FEMALE; HUMANS; INTERFERON ALFA-2B; MALE; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL ANALYSIS; TAMOXIFEN;

EID: 0036793759     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200210000-00007     Document Type: Article

References (19)

1. Kirkwood JM. Systemic therapy of melanoma. Curr Opin Oncol 1994;6:204-11.
2. Legha SS. The role of interferon alfa in the treatment of metastatic melanoma. Semin Oncol 1997;24:24-31.
3. McClay EF, McClay MET. Systemic chemotherapy for the treatment of metastatic melanoma. Semin Oncol 1996;23:744-53.
4. Richards JM, Mehta N, Ramming K, et al. Sequential chemoimmunotherapy in the treatment of metastatic melanoma. J Clin Oncol 1992;10:1338-43.
5. Hayward JL, Rubens RD. Assessment of response to therapy in advanced breast cancer. Br J Cancer 1977;345:292-8.
6. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-14.
7. Del-Prete SA, Maurer LH, O'Donnel J, et al. Combination chemotherapy with cisplatin, carmustine, dacarbazine and tamoxifen in metastatic melanoma. Cancer Treat Rep 1984;68:1403-5.
8. McClay EF, Mastrangelo MJ, Bellet RE, et al. Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma. Cancer Treat Rep 1987;71:465-9.
9. McClay EF, Mastrangelo MJ, Sprandio JD, et al. The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma. Cancer 1989;63:1292-5.
10. Keilholz U, Stoter G, Punt CJA. Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer, Melanoma Cooperative Group. J Am Cancer Sci 1997;3:522-8.
11. Thomson DB, Adena M, McLeod GR, et al. Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial. Melanoma Res 1993;3:133-8.
12. Bajetta E, Di Leo A, Zampino MG, et al. Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma. J Clin Oncol 1994;12:806-11.
13. Falkson CL, Falkson G, Falkson HC. Improved results with the addition of interferon alfa-2β to dacarbazine in the treatment of patients with metastatic malignant melanoma. J Clin Oncol 1991;9:1403-8.
14. Feun LG, Savaraj N, Moffat F. Phase II trial of recombinant alpha-interferon [IFN] with BCNU, DTIC, cisplatin (DDP) and tamoxifen in advanced malignant melanoma [Abstract]. Proc Am Soc Clin Oncol 1993;12:391.
15. Chapman PB, Einhorn LH, Meyers ML, et al. I. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999;17:2745-51.
16. Sonnenblick M, Rosenmann D, Rosin A. Reversible cardiomyopathy induced by interferon. BMJ 1990;300:1174-5.
17. Sonnenblick M, Rosin A. Cardiotoxicity of interferon: a review of 44 cases. Chest 1991;99:557-61.
18. Stark JJ, Dillman RO, Schulof R, et al. Interferon-a and chemohormonal therapy for patients with advanced melanoma: final results of phase I-II studies of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program. Cancer 1998;82:1677-81.
19. Margolin KA, Liu PY, Flaherty LE, et al. Phase II study of carmustine, dacarbazine, cisplatin and tamoxifen in advanced melanomas. J Clin Oncol 1998;16:664-9.